1. Home
  2. ARCC vs ALGN Comparison

ARCC vs ALGN Comparison

Compare ARCC & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ares Capital Corporation

ARCC

Ares Capital Corporation

HOLD

Current Price

$18.25

Market Cap

12.8B

Sector

Finance

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$177.88

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCC
ALGN
Founded
2004
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
12.0B
IPO Year
2004
2000

Fundamental Metrics

Financial Performance
Metric
ARCC
ALGN
Price
$18.25
$177.88
Analyst Decision
Buy
Buy
Analyst Count
10
11
Target Price
$21.60
$192.40
AVG Volume (30 Days)
8.4M
1.1M
Earning Date
04-28-2026
04-29-2026
Dividend Yield
10.50%
N/A
EPS Growth
N/A
0.53
EPS
1.86
5.65
Revenue
N/A
$387,126,000.00
Revenue This Year
$6.39
$5.85
Revenue Next Year
$1.57
$4.45
P/E Ratio
$9.84
$30.50
Revenue Growth
N/A
23.95
52 Week Low
$17.59
$122.00
52 Week High
$23.42
$208.31

Technical Indicators

Market Signals
Indicator
ARCC
ALGN
Relative Strength Index (RSI) 39.63 51.03
Support Level $18.17 $173.58
Resistance Level $20.28 $186.51
Average True Range (ATR) 0.44 6.41
MACD -0.01 -0.84
Stochastic Oscillator 35.33 56.47

Price Performance

Historical Comparison
ARCC
ALGN

About ARCC Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: